Particle.news
Download on the App Store

IQVIA CEO Sells $26.1 Million in Stock Appreciation Rights

Conversion of equity compensation into cash preserved the CEO's large beneficial stake as IQVIA recorded $3.15 billion in bookings.

Overview

  • Ari Bousbib completed an exercise-and-sell of stock appreciation rights on July 29, 2026, selling 106,279 shares for about $26.1 million at a weighted average price of $245.51.
  • The sale price was a narrow discount to the $247.56 market close on July 29, 2026, and the underlying rights expire in February 2027, according to an SEC Form 4 filing reported on August 2.
  • The transaction lowered Bousbib's direct holdings by roughly 11% but left his total beneficial ownership at about 1.4 million shares, including 543,000 shares held indirectly through the Orohena Trust.
  • Company reporting released the same day highlighted operational strength, with IQVIA posting record bookings of $3.15 billion, a context investors use to judge insider liquidity moves.
  • The filing and coverage frame the move as a compensation-liquidity event rather than a shift in long-term alignment, but investors may watch for further insider sales or stock reactions tied to earnings and cash flow updates.